Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway

As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relati...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 20; no. 4; p. e0302766
Main Authors Tong, Wangxia, Qin, Na, Lu, Tao, Liu, Li, Liu, Rong, Chen, Jibing, Luo, Ning
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 03.04.2025
Public Library of Science (PLoS)
Subjects
RNA
Online AccessGet full text

Cover

Loading…
Abstract As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.
AbstractList As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.
As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.
As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.
Audience Academic
Author Liu, Li
Tong, Wangxia
Qin, Na
Luo, Ning
Liu, Rong
Lu, Tao
Chen, Jibing
AuthorAffiliation 1 Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
3 Department of hepatobiliary surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
King Faisal Specialist Hospital and Research Center, Saudi Arabia
4 Centre for Translational Medical Research in Integrative Chinese and Western Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
2 The Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
5 Department of Neurology, RuiKang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
AuthorAffiliation_xml – name: 5 Department of Neurology, RuiKang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
– name: 2 The Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China
– name: 4 Centre for Translational Medical Research in Integrative Chinese and Western Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
– name: 3 Department of hepatobiliary surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
– name: King Faisal Specialist Hospital and Research Center, Saudi Arabia
– name: 1 Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China
Author_xml – sequence: 1
  givenname: Wangxia
  surname: Tong
  fullname: Tong, Wangxia
– sequence: 2
  givenname: Na
  surname: Qin
  fullname: Qin, Na
– sequence: 3
  givenname: Tao
  surname: Lu
  fullname: Lu, Tao
– sequence: 4
  givenname: Li
  surname: Liu
  fullname: Liu, Li
– sequence: 5
  givenname: Rong
  surname: Liu
  fullname: Liu, Rong
– sequence: 6
  givenname: Jibing
  surname: Chen
  fullname: Chen, Jibing
– sequence: 7
  givenname: Ning
  orcidid: 0000-0002-3892-524X
  surname: Luo
  fullname: Luo, Ning
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40179068$$D View this record in MEDLINE/PubMed
BookMark eNqNk11v0zAUhiM0xLbCP0BgCQnBRVs7TmznClXjY9UmirrCreU4zsdI4mI7hf4PfjAOzaYG7QJFSpyT57wnfn3OeXDS6lYFwXMEZwhTNL_VnWlFPdv68AxiGFJCHgVnKMHhlIQQnxytT4Nza28hjDEj5ElwGkFEE0jYWfB72TpVGOGqtgBpV38Hos2A9W-1mkpV12D9eQGs-tGpVvaMUTslagtuLvH7EIGt0Y12yoJSbYXTfUZXCwOkMB7XjeiJwihrK92CdA-EdNXuUM6VCnxZ4qv54mozbzarNfAS5U-xfxo8zn0N9Wx4ToKvHz9sLi6n16tPy4vF9VSSKHJTlCFKQ5amkOFYMsyoTBDNMc5jwVhO0pxFWRiyECmKBA5Tz2ZRkpOEZjBSEk-Clwfdba0tHwy1HCNGwgRFCfXE8kBkWtzyrakaYfZci4r_DWhTcGFcJWvFfUpCcpqmGVIRjWkSRzAJERYszUOa9Vrvhmpd2qhMqtYZUY9Ex1_aquSF3nGEEkITAr3Cm0HBaH8g1vGmsr3lolW6O_w4jhH25zwJXv2DPry9gSqE30HV5toXlr0oXzCMGST-5qnZA5S_MtVU0rdfXvn4KOHtKMEzTv1yheis5cub9f-zq29j9vURW_o-dKXVded8b9kx-OLY6nuP7_reA9EBkEZba1R-jyDI-_G6s4v348WH8cJ_AHyKFjQ
Cites_doi 10.1016/j.cell.2017.04.001
10.3390/biomedicines9111639
10.1038/s41568-018-0074-8
10.4049/jimmunol.1601515
10.1038/nri.2016.80
10.1016/S0140-6736(18)30010-2
10.1016/j.semcancer.2019.07.003
10.1093/annonc/mdv474
10.3748/wjg.v24.i31.3500
10.1101/cshperspect.a006098
10.1053/j.semdp.2016.12.011
10.1038/s41587-020-0546-8
10.1146/annurev-immunol-032712-095946
10.3390/nu14010067
10.1038/s41598-019-55893-2
10.1093/nar/gkac947
10.1002/hep.31288
10.1186/s40608-017-0145-5
10.3389/fonc.2014.00064
10.3390/ijms21124414
10.1038/s41392-021-00484-9
10.1007/978-1-0716-1307-8_19
10.1158/2159-8290.CD-12-0095
10.1093/nar/gkz401
10.1016/S1470-2045(21)00604-5
10.1056/NEJMra1713263
10.1016/S1470-2045(22)00326-6
10.1038/s41575-022-00704-9
10.1038/s41467-022-32283-3
10.1177/0022034520910127
10.1007/s11912-022-01247-7
10.1038/nmeth.4402
10.1038/nature13490
10.1038/nature19834
ContentType Journal Article
Copyright Copyright: © 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2025 Public Library of Science
2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2025 Tong et al 2025 Tong et al
2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2025 Public Library of Science
– notice: 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2025 Tong et al 2025 Tong et al
– notice: 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0302766
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
In Context: Opposing Viewpoints
In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Agricultural Science Database


CrossRef
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate SH3D21 promotes hepatocellular carcinoma progression
EISSN 1932-6203
ExternalDocumentID 3186291497
oai_doaj_org_article_62996f7bbd1e475795409213a8bf27d7
PMC11967960
A833806338
40179068
10_1371_journal_pone_0302766
Genre Journal Article
GeographicLocations China
United States
Massachusetts
Illinois
United States--US
GeographicLocations_xml – name: China
– name: United States
– name: Massachusetts
– name: Illinois
– name: United States--US
GrantInformation_xml – grantid: none
– grantid: 2021GXNSFAA196031
– fundername: ;
  grantid: 82060843
– fundername: ;
  grantid: 82260860
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c644t-1d17728bb0835c8387c917f33f5a88f6bf84d22821e71a32b28bd49f697d04ec3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Wed Aug 13 01:18:50 EDT 2025
Wed Aug 27 01:20:21 EDT 2025
Thu Aug 21 18:38:16 EDT 2025
Fri Jul 11 18:50:20 EDT 2025
Fri Jul 25 11:15:05 EDT 2025
Tue Jun 17 21:58:05 EDT 2025
Tue Jun 10 20:58:41 EDT 2025
Fri Jun 27 05:14:47 EDT 2025
Fri Jun 27 05:14:36 EDT 2025
Thu May 22 21:23:44 EDT 2025
Sat May 17 01:30:15 EDT 2025
Tue Jul 01 05:14:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright: © 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c644t-1d17728bb0835c8387c917f33f5a88f6bf84d22821e71a32b28bd49f697d04ec3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
JC and NL also contributed equally to this work.
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-3892-524X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0302766
PMID 40179068
PQID 3186291497
PQPubID 1436336
PageCount e0302766
ParticipantIDs plos_journals_3186291497
doaj_primary_oai_doaj_org_article_62996f7bbd1e475795409213a8bf27d7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11967960
proquest_miscellaneous_3186351305
proquest_journals_3186291497
gale_infotracmisc_A833806338
gale_infotracacademiconefile_A833806338
gale_incontextgauss_ISR_A833806338
gale_incontextgauss_IOV_A833806338
gale_healthsolutions_A833806338
pubmed_primary_40179068
crossref_primary_10_1371_journal_pone_0302766
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-04-03
PublicationDateYYYYMMDD 2025-04-03
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-03
  day: 03
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2025
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References C Porta (pone.0302766.ref011) 2014; 4
Y Sunakawa (pone.0302766.ref034) 2015; 26
G Giannone (pone.0302766.ref025) 2020; 21
JN Hellwege (pone.0302766.ref015) 2017; 4
A Villanueva (pone.0302766.ref001) 2019; 380
C-F Tsai (pone.0302766.ref028) 2021; 14
X Qiu (pone.0302766.ref021) 2017; 14
X Xiang (pone.0302766.ref035) 2021; 6
MJ Goldman (pone.0302766.ref017) 2020; 38
DE Speiser (pone.0302766.ref027) 2016; 16
MM Kaneda (pone.0302766.ref030) 2016; 539
X Wu (pone.0302766.ref031) 2020; 99
T Yau (pone.0302766.ref006) 2022; 23
R Sever (pone.0302766.ref009) 2015; 5
K Okkenhaug (pone.0302766.ref026) 2013; 31
EJ Sun (pone.0302766.ref010) 2021; 9
X-N Yu (pone.0302766.ref012) 2019
Q Zhang (pone.0302766.ref029) 2018; 24
Y Lu (pone.0302766.ref022) 2022; 13
KA McGlynn (pone.0302766.ref007) 2021
J Hartke (pone.0302766.ref004) 2017; 34
C Hu (pone.0302766.ref020) 2023; 51
AK Murugan (pone.0302766.ref014) 2019; 59
Y Liao (pone.0302766.ref018) 2019; 47
S Slovin (pone.0302766.ref019) 2021
BD Manning (pone.0302766.ref008) 2017; 169
E Vergadi (pone.0302766.ref032) 2017; 198
OR Colegio (pone.0302766.ref033) 2014; 513
M Masoudi (pone.0302766.ref023) 2019; 9
C Yang (pone.0302766.ref013) 2023; 20
E Cerami (pone.0302766.ref016) 2012; 2
A Forner (pone.0302766.ref002) 2018; 391
RK Kelley (pone.0302766.ref005) 2022; 23
KM Wong (pone.0302766.ref003) 2022; 24
D Mossmann (pone.0302766.ref024) 2018; 18
References_xml – volume: 169
  start-page: 381
  issue: 3
  year: 2017
  ident: pone.0302766.ref008
  article-title: AKT/PKB signaling: navigating the network
  publication-title: Cell
  doi: 10.1016/j.cell.2017.04.001
– volume: 9
  start-page: 1639
  issue: 11
  year: 2021
  ident: pone.0302766.ref010
  article-title: Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
  publication-title: Biomedicines
  doi: 10.3390/biomedicines9111639
– volume: 18
  start-page: 744
  issue: 12
  year: 2018
  ident: pone.0302766.ref024
  article-title: mTOR signalling and cellular metabolism are mutual determinants in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0074-8
– volume: 198
  start-page: 1006
  issue: 3
  year: 2017
  ident: pone.0302766.ref032
  article-title: Akt signaling pathway in macrophage activation and M1/M2 polarization
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1601515
– volume: 16
  start-page: 599
  issue: 10
  year: 2016
  ident: pone.0302766.ref027
  article-title: Regulatory circuits of T cell function in cancer
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.80
– volume: 391
  start-page: 1301
  issue: 10127
  year: 2018
  ident: pone.0302766.ref002
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)30010-2
– volume: 59
  start-page: 92
  year: 2019
  ident: pone.0302766.ref014
  article-title: mTOR: Role in cancer, metastasis and drug resistance
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2019.07.003
– volume: 26
  start-page: 2450
  issue: 12
  year: 2015
  ident: pone.0302766.ref034
  article-title: Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdv474
– volume: 24
  start-page: 3500
  issue: 31
  year: 2018
  ident: pone.0302766.ref029
  article-title: Immunometabolism: a novel perspective of liver cancer microenvironment and its influence on tumor progression
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i31.3500
– volume: 5
  start-page: a006098
  issue: 4
  year: 2015
  ident: pone.0302766.ref009
  article-title: Signal transduction in cancer
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a006098
– volume: 34
  start-page: 153
  issue: 2
  year: 2017
  ident: pone.0302766.ref004
  article-title: The diagnosis and treatment of hepatocellular carcinoma
  publication-title: Semin Diagn Pathol
  doi: 10.1053/j.semdp.2016.12.011
– volume: 38
  start-page: 675
  issue: 6
  year: 2020
  ident: pone.0302766.ref017
  article-title: Visualizing and interpreting cancer genomics data via the Xena platform
  publication-title: Nat Biotechnol
  doi: 10.1038/s41587-020-0546-8
– volume: 31
  start-page: 675
  year: 2013
  ident: pone.0302766.ref026
  article-title: Signaling by the phosphoinositide 3-kinase family in immune cells
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032712-095946
– volume: 14
  start-page: 67
  issue: 1
  year: 2021
  ident: pone.0302766.ref028
  article-title: Regulatory effects of quercetin on M1/M2 macrophage polarization and oxidative/antioxidative balance
  publication-title: Nutrients
  doi: 10.3390/nu14010067
– volume: 9
  start-page: 19188
  issue: 1
  year: 2019
  ident: pone.0302766.ref023
  article-title: A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-55893-2
– volume: 51
  start-page: D870
  issue: D1
  year: 2023
  ident: pone.0302766.ref020
  article-title: CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkac947
– start-page: 4
  issue: Suppl 1
  year: 2021
  ident: pone.0302766.ref007
  article-title: Epidemiology of hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.31288
– volume: 4
  start-page: 12
  year: 2017
  ident: pone.0302766.ref015
  article-title: Association of gene coding variation and resting metabolic rate in a multi-ethnic sample of children and adults
  publication-title: BMC Obes
  doi: 10.1186/s40608-017-0145-5
– volume: 4
  start-page: 64
  year: 2014
  ident: pone.0302766.ref011
  article-title: Targeting PI3K/Akt/mTOR signaling in cancer
  publication-title: Front Oncol
  doi: 10.3389/fonc.2014.00064
– volume: 21
  start-page: 4414
  issue: 12
  year: 2020
  ident: pone.0302766.ref025
  article-title: Immuno-metabolism and microenvironment in cancer: key players for immunotherapy
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21124414
– volume: 6
  start-page: 75
  issue: 1
  year: 2021
  ident: pone.0302766.ref035
  article-title: Targeting tumor-associated macrophages to synergize tumor immunotherapy
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00484-9
– start-page: 343
  year: 2021
  ident: pone.0302766.ref019
  article-title: Single-cell RNA sequencing analysis: a step-by-step overview
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-0716-1307-8_19
– volume: 2
  start-page: 401
  issue: 5
  year: 2012
  ident: pone.0302766.ref016
  article-title: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-12-0095
– volume: 47
  start-page: W199
  issue: W1
  year: 2019
  ident: pone.0302766.ref018
  article-title: WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz401
– volume: 23
  start-page: 77
  issue: 1
  year: 2022
  ident: pone.0302766.ref006
  article-title: Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(21)00604-5
– volume: 380
  start-page: 1450
  issue: 15
  year: 2019
  ident: pone.0302766.ref001
  article-title: Hepatocellular carcinoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1713263
– volume: 23
  start-page: 995
  issue: 8
  year: 2022
  ident: pone.0302766.ref005
  article-title: Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(22)00326-6
– volume: 20
  start-page: 203
  issue: 4
  year: 2023
  ident: pone.0302766.ref013
  article-title: Evolving therapeutic landscape of advanced hepatocellular carcinoma
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-022-00704-9
– volume: 13
  start-page: 4594
  issue: 1
  year: 2022
  ident: pone.0302766.ref022
  article-title: A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-32283-3
– volume: 99
  start-page: 577
  issue: 5
  year: 2020
  ident: pone.0302766.ref031
  article-title: Akt2 affects periodontal inflammation via altering the M1/M2 ratio
  publication-title: J Dent Res
  doi: 10.1177/0022034520910127
– start-page: 379
  issue: 2
  year: 2019
  ident: pone.0302766.ref012
  article-title: Targeting the mTOR regulatory network in hepatocellular carcinoma: are we making headway?
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 24
  start-page: 917
  issue: 7
  year: 2022
  ident: pone.0302766.ref003
  article-title: The treatment landscape of advanced hepatocellular carcinoma
  publication-title: Curr Oncol Rep
  doi: 10.1007/s11912-022-01247-7
– volume: 14
  start-page: 979
  issue: 10
  year: 2017
  ident: pone.0302766.ref021
  article-title: Reversed graph embedding resolves complex single-cell trajectories
  publication-title: Nat Methods
  doi: 10.1038/nmeth.4402
– volume: 513
  start-page: 559
  issue: 7519
  year: 2014
  ident: pone.0302766.ref033
  article-title: Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
  publication-title: Nature
  doi: 10.1038/nature13490
– volume: 539
  start-page: 437
  issue: 7629
  year: 2016
  ident: pone.0302766.ref030
  article-title: PI3Kγ is a molecular switch that controls immune suppression
  publication-title: Nature
  doi: 10.1038/nature19834
SSID ssj0053866
Score 2.4778185
Snippet As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21...
As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0302766
SubjectTerms 1-Phosphatidylinositol 3-kinase
Adaptor Proteins, Signal Transducing - genetics
Adaptor Proteins, Signal Transducing - metabolism
AKT protein
Analysis
Bioinformatics
Biological effects
Biology and Life Sciences
Biomarkers
Biomarkers, Tumor - genetics
Cancer
Cancer therapies
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Cell cycle
Cell Line, Tumor
Cell Movement - genetics
Cell Proliferation - genetics
Chemotherapy
Cholecystokinin
Datasets
Development and progression
Disease Progression
Female
Gene expression
Gene Expression Regulation, Neoplastic
Gene sequencing
Genes
Genetic aspects
Genomes
Genomics
Health aspects
Hepatocellular carcinoma
Hepatoma
Humans
Immunotherapy
Kinases
Liver cancer
Liver Neoplasms - genetics
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Male
Medical prognosis
Medicine and Health Sciences
Membrane proteins
Metabolism
Oncology, Experimental
Phosphatidylinositol 3-Kinases - genetics
Phosphatidylinositol 3-Kinases - metabolism
Prognosis
Protein kinases
Proto-Oncogene Proteins c-akt - genetics
Proto-Oncogene Proteins c-akt - metabolism
Quality control
RNA
RNA sequencing
Sequence Analysis, RNA
Signal Transduction
Single-Cell Analysis
Software
Therapeutic targets
TOR protein
TOR Serine-Threonine Kinases - genetics
TOR Serine-Threonine Kinases - metabolism
Traditional Chinese medicine
Tumor microenvironment
Tumor Microenvironment - genetics
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK8VChiEBDxkbWwndh_Lx9SC2FC3ob1ZduwwRJdUtAXt_-AP5i52w4ImwQOv9cWu787n3yXnnwl5hiRh1jifSOFNIlLHE8M5hyyFWeWsyhzDA84fDvLpiXh3mp1euuoLa8ICPXBQ3DCHeJmX0lqXeiEzOQaIMYYRjLIlk645Rw573jaZCjEYVnGex4NyXKbDaJe9ZV35vRF-qmtYEX9vRA1ffxuVe8tFvboKcv5ZOXlpK9q_SW5EDEkn4b_vkGu-ukV24ipd0ReRSvrlbfJzFtkgYIOidrP4Sk3lKL4eWPgE39nT-cGExnJqlEFCJ3BIejTlb1hKl02xHvR5BrvWusYnsGyVFngDUVWfG9rUdwVuD2ovKB6T-B6GA2RJP874-yHAyOH58eGc4u3HP8zFHXKy__b49TSJ9zAkBaCldZK6FDC4shbhWqG4kgUkeSXnZWaUKnNbKuEY5G6pl6nhzIKsE-MyH0s3Er7gd0mvAs3vEmoyQBCeOSZyI5D93TAFCMyrwjsF_fVJsjWKXga6Dd18c5OQpgTtajSijkbsk1douVYWybKbH8CFdHQh_TcX6pPHaHcdTp62S15PFOTvAOG46pOnjQQSZlRYkfPZbFYrPTv89A9CR_OO0PMoVNbgQYWJpyBgTkjE1ZEcdCRh2Red5l300q1WVhqCM0wUEl6Yz2DruVc3P2mbsVOssqt8vQkyPANUA3a4Fxy91azA0D3KYVzVWQId1Xdbqi9nDV95ClFeQqZ8_38Y6wG5zvAKZiye4gPSW3_b-IeAC9f2URMCfgEg7l9O
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegvPCCGF8rG2AQEvCQtbGT2HlC5aO0IDbUbWhvkR07G6JLsqUF7f_gD-YucTKCJsRrfXEa3539O_v8O0KeI0mYVsZ6IrDKC3zDPcU5hyiFaWm0DA3DC86fd6PZYfDxKDxyG26VS6ts58R6ojZFinvkI7C9iMWA58Xr8szDqlF4uupKaFwnN3xYaTClS04_tDMx-HIUuetyXPgjp52dssjtzhgP7GpuxMvlqGbt7-bmQbksqquA59_5k38sSNPb5JZDknTSqH6DXLP5HbLhfLWiLx2h9Ku75NfccULAMkX1evmdqtxQ3CRYWg937ulid0JdUjXKIK0TmCXdn_F3zKdlnbIHfZ7A2rUq8AlMXqUp1iHKi1NF6yyvhuGD6guKlyV-NK8DfEm_zPmnEYDJ0enB3oJiDeSf6uIeOZy-P3g781w1Bi8FzLTyfOMDEpdaI2hLJZcihVAv4zwLlZRZpDMZGAYRnG-FrzjTIGuCOItiYcaBTfl9Mshh5DcJVSHgCMsMCyIVIAe8YhJwmJWpNRL6GxKvVUpSNqQbSX3yJiBYaUY3QSUmTolD8gY118kiZXb9Q3F-nDgPTMB64igTWhvfBiIUMWDVGExVSZ0xYcSQPEG9J839087xk4mEKB6AHJdD8qyWQNqMHPNyjtW6qpL53tf_ENpf9IReOKGsAAtKlbsLAd-EdFw9ye2eJDh_2mveRCttR6VKLt0Enmwt9-rmp10zdoq5drkt1o0MDwHbgB4eNIbejWyAE_g4gvfKngv0hr7fkn87qVnLfZjrBcTLD__9v7bITYYlljE5im-Twep8bR8B7lvpx7Vz_wa5DFe6
  priority: 102
  providerName: ProQuest
Title Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
URI https://www.ncbi.nlm.nih.gov/pubmed/40179068
https://www.proquest.com/docview/3186291497
https://www.proquest.com/docview/3186351305
https://pubmed.ncbi.nlm.nih.gov/PMC11967960
https://doaj.org/article/62996f7bbd1e475795409213a8bf27d7
http://dx.doi.org/10.1371/journal.pone.0302766
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELe27oUXxPi3QikGIQEP6Zo4id0HhLrR0oLWTd069S2yY2dDdElpWqAvfAo-MHdJGhFUJMSLH-KzI9_Z59_Z5ztCXmCQMCW1sbhrpOXamlmSMQZWiqOEVsLTDj5wPhn5g4n7YepNd8gmZ2vBwHSraYf5pCaLWev7l_VbWPBvsqwN3N40as2T2LTaeBHn-7tkD_YmjjkNTtzyXgFWt-8XD-j-1rKyQWVx_EttXZvPknQbFP3To_K3Lap_h9wusCXt5pNhn-yY-C7ZL1ZvSl8VIaZf3yM_h0WUCNi4qFrNPlMZa4rHBjNj4Vk-HY-6tHCzRhoM9AQMo-cD9s6x6Txz4oM-r2E3WybYAt1ZaYiZieLkRtLM7yuP-UHVmuLzia_57wBx0rMh-3gI8PLw5uJ0TDEr8je5vk8m_d7F8cAq8jNYIaCopWVrG7C5UAphXCiY4CEYfxFjkSeFiHwVCVc7YNPZhtuSOQpotduJ_A7XbdeE7AGpxcD5A0KlB8jCONpxfeliVHjpCEBmRoRGC-ivTqyNUIJ5HoYjyO7iOJgvOXcDFGJQCLFOjlByJS0G0c4-JIuroFiTgQ9bsR9xpbRtXO7xDqDXDkxeKVTkcM3r5CnKPchfpJaqIOgKsOsB2jFRJ88zCgykEaOnzpVcpWkwPL38B6LzcYXoZUEUJTCDQlm8joAxYYCuCmWjQgnqIKxUH-As3XAlDUBpw0DBEIbxNDYzd3v1s7IaO0Xvu9gkq5yGeYB2QA4P84lectZFld724b-isgQqrK_WxJ-uszjmNmh_Dhb0o_9v-pjccjAhM7pSsQapLRcr8wRQ4lI1yS6fcijFsY1l_32T7B31RmfjZnbu0swUA5Y_er8Agh5vrw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lc9MwENaUcIALQ3k1UKhgYICDm1iyLeXAMIESEtKmTJt2ejOSJbcMqR3qhE7-B7-D38iuHylmOgyXXqO1kmhf31r7IOQ5NgnTylhHeFY5nmu4ozjnEKUwLY2WvmFY4LwzCvoH3qcj_2iF_KpqYTCtsrKJuaE2aYTvyFsgewHrAJ4Xb6ffHZwahber1QiNQiyGdnEOIVv2ZrAF_H3BWO_D-H3fKacKOBH4_pnjGhcQpdQawUckuRQRhCwx57GvpIwDHUvPMIhEXCtcxZkGWuN14qAjTNuzEYd9r5HrHgdPjpXpvY-V5QfbEQRleR4XbquUhs1pmtjNNl4Q5r0YL9xfPiVg6Qsa00maXQZ0_87X_MMB9m6TWyVypd1C1FbJik3ukNXSNmT0VdnA-vVd8nNQ9qAAt0j1fPKNqsRQfCkxsQ7eFNC9UZeWSdxIg22kQA3ofp9vMZdO8xRB2PMEfOUsxScwWZZGOPcoSU8VzbPKio4iVC8oFmf8KL4O8Cz9PODDFoDX1ul4d4_izOVztbhHDq6ET_dJI4GTXyNU-YBbLDPMC5SHPecVk4D7rIyskbBfkzgVU8Jp0eQjzG_6BARHxemGyMSwZGKTvEPOLWmxRXf-QXp2HJYaH4K0doJYaG1c6wlfdAAbd0A1lNQxE0Y0yQbyPSzqXZeGJuxKziUARy6b5FlOgW06EswDOlbzLAsHu4f_QbS_VyN6WRLFKUhQpMraC_hP2P6rRrleowRjE9WW11BKq1PJwgu1hCcryb18-elyGTfF3L7EpvOChvuApYAPDwpBX56shw6jHcD3ypoK1I6-vpJ8Pcm7pLvgWwTE5w___bs2yI3-eGc73B6Mho_ITYbjnTExi6-Txuxsbh8D5pzpJ7miU_Llqi3Lb7pak3g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkRAviHFbYTCDQMBD1sZOY_cBobJStRS6qdvQ3oIdOxuiS8raMvV_8Gv4dZyTOB1BE-Jlr_WJ2_rcvhOfCyHPsUmYVsZ6IrDKC3zDPcU5hyiFaWm0bBmGBc6fRmH_MPhw1DpaI7_KWhhMqyxtYm6oTRbjO_IGyF7I2oDnRSNxaRF73d7b6XcPJ0jhTWs5TqMQkaFdnkP4Nnsz6AKvXzDWe3-w0_fchAEvBhww93zjA7qUWiMQiSWXIobwJeE8aSkpk1AnMjAMohLfCl9xpoHWBO0kbAvTDGzMYd9r5LrgQqKOyZ1VegnYkTB0pXpc-A0nGdvTLLXbTbwszPsyXrjCfGLAyi_UppNsdhno_Tt38w9n2LtNbjkUSzuF2K2TNZveIevOTszoK9fM-vVd8nPg-lGAi6R6MflGVWoovqCYWA9vDeh41KEuoRtpsKUUqATd7_Mu8-k0TxeEPU_Ab84zfAITZ2mMM5DS7FTRPMOs6C5C9ZJiocaP4usA29K9AR82AMg2Tg92xxTnL5-r5T1yeCV8uk9qKZz8BqGqBRjGMsOCUAXYf14xCRjQytgaCfvViVcyJZoWDT-i_NZPQKBUnG6ETIwcE-vkHXJuRYvtuvMPsrPjyGl_BJLbDhOhtfFtIFqiDTi5DWqipE6YMKJOtpDvUVH7ujI6UUdyLgFEclknz3IKbNmRovAfq8VsFg12P_8H0f64QvTSESUZSFCsXB0G_CdsBVah3KxQguGJK8sbKKXlqcyiCxWFJ0vJvXz56WoZN8U8v9Rmi4KGtwBXAR8eFIK-OtkAnUczhO-VFRWoHH11Jf16kndM98HPCIjVH_77d22RG2BToo-D0fARuclw0jPmaPFNUpufLexjgJ9z_STXc0q-XLVh-Q044pd5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integrating+bulk+and+single-cell+RNA+sequencing+reveals+SH3D21+promotes+hepatocellular+carcinoma+progression+by+activating+the+PI3K%2FAKT%2FmTOR+pathway&rft.jtitle=PloS+one&rft.au=Tong%2C+Wangxia&rft.au=Qin%2C+Na&rft.au=Lu%2C+Tao&rft.au=Liu%2C+Li&rft.date=2025-04-03&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=20&rft.issue=4&rft_id=info:doi/10.1371%2Fjournal.pone.0302766&rft.externalDocID=PMC11967960
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon